- TRADE NAMES: Aristocort; Aristospan (Sabex); Azmacort (Kos); Kenacort; Kenalog (Apothecon); Nasacort (Aventis); Triacet (Teva)
- INDICATIONS: Arthralgias, asthma, dermatoses, inflammatory ocular conditions, rhinitis
- CLASS: Corticosteroid / Glucocorticoid, Corticosteroid, systemic, Corticosteroid, topical
- HALF-LIFE: 17–25 days
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Acetazolamide, Adrenergic neurone blockers, Aldesleukin, Alpha blockers, Aminoglutethimide, Aminophylline, Amphotericin B, Angiotensin II receptor antagonists, Antacids, Antidiabetics, Antifungals, Aprepitant, Aspirin, Barbiturates, Beta blockers, Beta2 sympathomimetics, Calcium channel blockers, Calcium salts, Carbamazepine, Cardiac glycosides, Clonidine, Denosumab, Diazoxide, Diuretics, Erythromycin, Estrogens, Fluconazole, Fosaprepitant, Histamine, Hydralazine, Isoniazid, Itraconazole, Ketoconazole, Leflunomide, Leflunomide, Live vaccines, Loop diuretics, Macrolide antibiotics, Methyl salicylate, Methyldopa, Mifamurtide, Mifepristone, Minoxidil, Mitotane, Moxonidine, Natalizumab, Neuromuscular blocking agents, Nitrates, Nitroprusside, NSAIDs, Oral Contraceptives, Pancuronium, Phenindione, Phenobarbital, Phenytoin, Pimecrolimus, Primidone, Quinolones, Rifampin, Rifamycin derivatives, Salicylates, Sipuleucel-T, Sodium benzoate, Sodium phenylbutyrate, Somatropin, Tacrolimus, Thiazides, Vaccines, Vecuronium, Warfarin
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of intravitreal triamcinolone in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 02/07/2025
